Search the Newsreel

Balyasny Asset Management (LXEO) discloses 7.84M-share Lexeo Therapeutics stake capped at 9.99%

Balyasny Asset Management and its affiliated entities have disclosed a beneficial ownership of 7,844,311 shares of Lexeo Therapeutics, Inc. (LXEO) common stock, representing 9.99% of the outstanding shares. This stake includes shares directly held by Atlas Diversified Master Fund and Atlas Private Holdings, with …

Following Wynca Group and Hubei Xingfa's Expansion in IDA-Based Synthesis Routes, New Study Projects $1.1 Billion Phosphorus Trichloride Market for Glyphosate

Company Logo Sustained global demand for crop protection products and broader adoption of low-waste synthesis routes, highlighted by process optimizations and capacity positioning across Wynca Group, Hubei Xingfa Chemicals Group Co., Ltd., LANXESS AG, ICL Group, and Xuzhou Yongda Chemical Co., Ltd. are driving …

ETFs Investing in Exelon Corporation Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Exelon Corporation (1EXC) stocks. It details various ETFs, their market value of Exelon holdings, weight percentage, issuer, management style, expense ratio, assets under management (AUM), current price, change, relative volume, and …

XERS|Xeris Biopharma Holdings Inc|Price:8.322|Chg%:-0.168

This page provides an overview of Xeris Biopharma Holdings Inc (XERS), including its live stock price, key financial figures, technical analysis, and analyst ratings. The company, which specializes in developing and commercializing products for various therapies like Cushing's syndrome and severe hypoglycemia, currently holds …

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Rating of "Buy" by Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) has received a consensus "Buy" rating from seventeen brokerages, with an average 12-month price target of $77.13. The company's stock is currently trading below its recent high, with institutional investors holding a significant 95.45% stake. Recent insider selling has also …

Exelon (EXC) Restores Power As Fair Value Still Sits Above The Stock

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Exelon (EXC) is back in focus after its Commonwealth Edison unit restored power to more than 80% of customers affected by severe storms …

CXDO insider plans 30,000-share sale in Nasdaq: CXDO Form 144 filing

David Wang, an insider at Crexendo, Inc. (CXDO), has filed a Form 144 to sell up to 30,000 shares of common stock through Wells Fargo Clearing Services, LLC, with an aggregate market value of $210,000. The filing also indicates Wang's current ownership of 193,366 …

Nexxen (NEXN) Stock Sees CTV Strength Collide With Profit Pressure

Nexxen International (NEXN) posted strong Q2 results with record programmatic revenue and raised full-year guidance, driven by growth in CTV and data products. Despite these gains, net income and EPS declined, leading to concerns about profitability amidst increased operating costs and investment intensity. The …

Xenon Pharmaceuticals Director Sold Shares Worth Over $640K

Steven Gannon, a Director at Xenon Pharmaceuticals (XENE), reported the sale of common shares totaling $640,550 on August 11, 2026. The transactions were executed at a weighted-average price of $64.055 per share. Following this sale, Gannon directly holds 1,870 common shares in the company.

(XNCR) as a Liquidity Pulse for Institutional Tactics

This article analyzes Xencor Inc. (NASDAQ: XNCR) based on AI models, identifying strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored …

(XHR) Volatility Zones as Tactical Triggers

Xenia Hotels & Resorts Inc. (NYSE: XHR) is exhibiting weak near and mid-term sentiment, potentially challenging its long-term positive outlook. The stock is testing resistance, with models suggesting a potential short setup offering a 28.8:1 risk-reward ratio targeting a 9.0% downside. Institutional trading strategies …

Deluxe (DLX) Shares Moved, What Is Drawing Attention Now?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Deluxe (DLX) has come into focus after raising its full year 2026 revenue guidance to a range of $2.095 billion to $2.120 billion, alongside …

Xenon Pharmaceuticals (XENE) Insider Sells 10,000 Shares; Direct

Director Steven Gannon of Xenon Pharmaceuticals (XENE) sold 10,000 shares for $64.06 per share, totaling $640,600, reducing his direct holdings to 1,870 shares. This sale contributes to a broader trend of 13 insider sells and no buys over the past year at Xenon, signaling …

MarketAxess Stock And Other Income Names Riding The Treasury Yield Revival

This article examines three stocks—MarketAxess Holdings (MKTX), WisdomTree (WT), and Northern Trust (NTRS)—that are exposed to the current environment of rising U.S. Treasury yields and increased government bond issuance. It discusses how each company stands to benefit or face challenges from these trends, highlighting …

Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript

Lexeo Therapeutics (LXEO): Affinity Asset Advisors reports 8.4% beneficial stake

Affinity Asset Advisors, LLC and Michael Cho have reported an 8.4% beneficial stake in Lexeo Therapeutics (LXEO) through an amended Schedule 13G filing. This includes 6,674,913 shares of common stock, with 867,302 shares issuable upon warrant exercise, as of June 30, 2026. The reporting …

MarketAxess (MKTX) director Emily Portney records 4,170-share gift transfers

MarketAxess Holdings Inc. director Emily Hope Portney reported two bona fide gift transactions involving 4,170 shares of common stock on August 12, 2026. One transaction involved the acquisition of 2,085 shares held directly, while another involved the disposition of 2,085 shares held indirectly "By …

Wellington group discloses 1.47% Xenon Pharmaceuticals (XENE) stake for advisory clients

Wellington Management Group LLP and its affiliates have reported a passive ownership stake of approximately 1.47% in Xenon Pharmaceuticals Inc. (XENE) common stock. This stake, representing 1,425,492 shares, is held for advisory clients across various Wellington investment entities, with no single client owning more …

Xenon Pharmaceuticals (XENE) director sells 10,000 common shares at $64

Xenon Pharmaceuticals director Steven Gannon sold 10,000 Common Shares on August 11, 2026, at a weighted-average price of $64.055 per share. The shares were sold in multiple transactions ranging from $64.0517 to $64.078. Following this transaction, Gannon directly holds 1,870 Common Shares of Xenon …

Wellington entities report 4.42% Xenia Hotels (XHR) stake held for clients

Wellington Management Group LLP and its related entities have reported a 4.42% beneficial ownership stake in Xenia Hotels & Resorts, Inc. (XHR) as of June 30, 2026. This stake, totaling 4,081,029 shares, is held for their investment advisory clients, with shared voting power over …

X-Energy, Inc. Class A (XE) Q2 2026 Earnings Report - Results, Call & Slides

X-Energy, Inc. (XE) released its Q2 2026 earnings report, missing EPS expectations but exceeding revenue forecasts. The company reported an actual EPS of -$0.15 against a consensus of -$0.10, while actual revenue was $54.60M compared to an expected $41.65M. An earnings call was held …

Nexxen International (NEXN) Stock Fair Value Edges Higher As Analysts Lift Targets

Analysts have increased their price targets for Nexxen International (NEXN), leading to an updated fair value for the stock of US$12.99, up from US$12.19. This revision is driven by strong Q2 results, increased exposure to connected TV, mobile in-app, and enterprise clients, and investments …

X-Energy outlines up to $1B more ARDP funding as NRC permit targets Q1 ’27

Earnings Call Insights: X-Energy (XE) Q2 2026 MANAGEMENT VIEW * CEO Clay Sell framed demand and market size by saying, "Based on third-party estimates, global electricity demand is expected to increase more than 75% by 2050" and "it's estimated that the market just for …

Xenia Hotels & Resorts (XHR) Is Down 8.1% After Equity Raise And Guidance Cut Has The Bull Case Changed?

Xenia Hotels & Resorts (XHR) recently completed a US$136.91 million equity offering and simultaneously cut its full-year 2026 earnings guidance, leading to an 8.1% stock drop. This move shifts the company's focus from share repurchases to balance sheet reinforcement amidst macroeconomic uncertainty. The new …

Are MKTX and CBZ Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating the sales of MarketAxess Holdings Inc. (MKTX) to Intercontinental Exchange, Inc. for $167.00 per share and CBIZ, Inc. (CBZ) to Grant Thornton Advisors LLC for $55.00 per share. The firm is examining whether these …

Canaccord Genuity Group Issues Positive Forecast for Nexxen International (NASDAQ:NEXN) Stock Price

Scotiabank Forecasts Strong Price Appreciation for Nexxen International (NASDAQ:NEXN) Stock

Scotiabank raised its price target for Nexxen International (NASDAQ:NEXN) to $13 from $11, maintaining a "sector outperform" rating and indicating a potential upside of 23.81%. This upgrade follows Nexxen's strong quarterly results, where EPS and revenue exceeded analyst expectations. Despite a slight dip in …

Xeris (XERS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President of Investor Relations - Allison Wey Chairman and Chief Executive Officer - John Shannon Chief Financial Officer - Steven Pieper Full Conference Call Transcript Operator: …

MarketAxess (MKTX): AQR Capital discloses 1.99M-share, 5.59% ownership stake

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 1,987,288 shares of MarketAxess Holdings Inc. common stock, representing a 5.59% stake. The filing indicates shared voting power over 1,947,559 shares and shared dispositive power over …

Nexxen International (NASDAQ:NEXN) Sets New 52-Week High Following Earnings Beat

NEXN Maintained by Rosenblatt -- Price Target Stays at $16.00

Canaccord raises Nexxen stock price target on CTV recovery momentum

Canaccord has increased its price target for Nexxen (NASDAQ:NEXN) to $13 from $11, maintaining a Buy rating, following the company's strong second-quarter results which exceeded consensus expectations. Nexxen's performance was driven by a robust recovery in connected TV, expanded enterprise customer spending, and growth …

Nexxen International DRC earnings beat by $0.03, revenue topped estimates

Renaissance Technologies LLC Takes Position in Deluxe Corporation $DLX

Renaissance Technologies LLC has acquired a new position in Deluxe Corporation (NYSE:DLX), purchasing 51,230 shares valued at approximately $1.41 million, representing a 0.11% stake in the company. Deluxe reported stronger-than-expected quarterly earnings and revenue, though revenue declined year-over-year. The company also declared a quarterly …

Hennion & Walsh Asset Management Inc. Invests $1.24 Million in Lexeo Therapeutics, Inc. $LXEO

Hennion & Walsh Asset Management Inc. has initiated a new position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO), purchasing 265,697 shares valued at approximately $1.24 million during the second quarter. This investment comes as institutional investors collectively own 60.67% of the company. Lexeo Therapeutics recently reported …

Exelixis (EXEL) Q2 2026 Earnings Call Transcript

Exelixis (EXEL) reported its Q2 2026 earnings, with total revenues reaching $628.7 million, a 10.6% increase year-over-year, driven by cabozantinib sales. The company updated its full-year 2026 revenue guidance downwards due to a more gradual sales ramp in the neuroendocrine tumor indication but reduced …